Tag:
elinogrel
Latest Headlines
Latest Headlines
Novartis set to begin late-stage testing of blood thinner
Portola Pharmaceuticals' partner Novartis will begin final-stage testing of the blood thinner elinogrel after researchers found the drug provides more rapid and greater antiplatelet activity than
Novartis inks $575M pact for Portola drug
Novartis has agreed to pay $75 million upfront and an additional $500 million in prospective milestones for the worldwide rights to Portola Pharmaceuticals' mid-stage anti-clotting therapeutic. In a
